Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Apple | 3.32% | $1.18B | $4.10T | 18.14% | 80 Outperform | |
| Johnson & Johnson | 3.30% | $1.17B | $500.07B | 33.56% | 78 Outperform | |
| JPMorgan Chase | 2.99% | $1.06B | $837.48B | 23.16% | 72 Outperform | |
| Exxon Mobil | 2.98% | $1.06B | $484.00B | -2.46% | 75 Outperform | |
| AbbVie | 2.84% | $1.01B | $402.36B | 24.35% | 62 Neutral | |
| Broadcom | 2.83% | $1.00B | $1.88T | 148.99% | 76 Outperform | |
| Microsoft | 2.80% | $994.93M | $3.61T | 14.78% | 73 Outperform | |
| Merck & Company | 2.22% | $787.04M | $259.69B | 1.46% | 76 Outperform | |
| Procter & Gamble | 2.09% | $741.49M | $346.42B | -17.34% | 74 Outperform | |
| Coca-Cola | 1.95% | $691.24M | $313.50B | 13.12% | 78 Outperform |